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The possibility that the rheumatoid factors represent antibodies to v-globulin 
has been entertained for a number of years. This concept originated primarily 
from the observations that the various serological tests for rheumatoid factors 
require v-globulin either as antibody or as inert material, in order for agglutina- 
tion to take place (1). The precipitin reaction with soluble aggregates of v-globu- 
lin  and  the  interaction  to  give a  complex detectable in  the  ultracentrifuge 
furnished additional evidence for this point of view (2-4). Recently, the demon- 
stmtion  that  these  factors  in  physical,  chemical,  and  antigenic  properties 
closely resembled classical antibodies of the 19S class, considerably strengthened 
the antibody concept (5-8). The apparent specificity for v-globulin, however, 
has not been clearly delineated. 
In 1956, Grubb and Laurell noted that certain rare rheumatoid sera could be 
utilized as test reagents for detecting genetic differences between human v-glob- 
ulins (9). These results were confirmed and extended by various investigators 
(10-12). However, although the genetic differences demonstrable by these tests 
have been widely utilized by human geneticists (13-19), they have contributed 
little to an understanding of the rheumatoid factors involved. The possibility 
arose that a study of the interaction of different rheumatoid factors with a wide 
variety of v-globulins from single individuals might reveal specificity for cer- 
tain  types of "}'-globulin. Such specificity would considerably strengthen  the 
antibody concept and perhaps throw light on the hypothesis that the rheuma- 
toid factors represent autoantibodies directed against the patient's own type of 
v-globulin. Recent work by Oudin,  Dray,  and others have indicated a  wide 
variety of antigenically different v-globulins in different individuals of the same 
species (20-25). A modification (26) of the test system of Waller and Vaughan, 
utilizing  incomplete  Rh  antibodies  from  single  donors  as  a  test  system for 
rheumatoid  factors,  has  been  primarily  employed in  the  present  investiga- 
tion (27). 
The results indicate a high degree of specificity for the reaction between indi- 
vidual rheumatoid factors and v-globulin in the form of incomplete Rh anti- 
bodies from single individuals.  A large number of different rheumatoid factors 
are distinguishable according  to their reactivity with such individual v-globu- 
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lins.  The  somewhat  surprising  observation  was  made  that  the  rheumatoid 
factors in many instances  react poorly with the patient's own ")'-globulin com- 
pared  to that of certain other individuals.  A  short  report  of these findings was 
presented  previously (28). 
Materials and Methods 
Rheumatoid Sera.--Thirty-six sera were obtained from patients with severe chronic deform- 
ing rheumatoid arthritis, most of whom were regularly seen at the Hospital of The Rockefeller 
Institute. All sera had titers greater than 5120 in the F-11 latex fixation test. Selected sera from 
patients with chronic liver disease, ~ sarcoidosis,  Waidenstr6m's macroglobulinemia, and idio- 
pathic pulmonary fibrosis were also utilized. Highly selected rheumatoid sera, useful as typing 
reagents for one or another of the hereditary T-globulin groups in man, were obtained through 
the kindness of Dr. R. Grubb,  Dr. M. Harboe,  Dr.  C. Ropartz, and Dr. A. Steinberg. 
"Coaling"  Reagents.--Twenty-four  high titer  "incomplete"  anti-Rho  sera from different 
persons were obtained from various hospitals and commercial blood banks in the New York 
City area. This antibody had developed in 16 instances in Rh-negative females during preg- 
nancy, and in 8 instances was produced by deliberate immunization of volunteer Rh-negative 
males. With two donors, samples were obtained at three different times during a 2-year period 
of continuing immunization. These six specimens and six additional ones were coded by number 
so that specimens from the same individual could not be identified as such until conclusion of 
the experiments. Anti-Rho (anti-D) antibodies were produced in selected Rh-negative patients 
with rheumatoid arthritis by immunization with 5 ml of a mixture of whole blood and Alsever's 
solution twice weeldy for 3 to 6 weeks. Four coating reagents containing incomplete antibodies 
other than anti-Rho were also employed; one sera contained anti-c, one anti-C (anti-th'), one 
anti-Duffy, and the fourth anti-Kell. One serum possessed  both incomplete anti-C and incom- 
plete anti-D activity; these were separable by absorption. This combination was produced by 
deliberate immunization, first with Rho erythrocytes and later with rh' erythrocytes. 
Rabbit  amboceptors.--Twelve  amboceptors  from individual non-litter mate rabbits of dif- 
ferent breeds were obtained from the Baltimore Biological Laboratories. 
Erythrocytes.--Whole  blood was obtained from the same human O Ro donor at 2 week in- 
tervals, mixed with an equal volume of  Alsever's solution and stored at 4°C. For selected ex- 
periments involving antibodies other than anti-Rh o, donors with red cells of appropriate anti- 
genic composition were employed, e.g., R2R~, RIR1, Fy  ~+, Kell  +. Sheep whole blood, obtained 
from Cappel Laboratories, was preserved in a similar manner. 
Rheumatoid Factor Activity.--F-II latex fixation (29), F-II tanned cell (30), and sensitized 
sheep cell (SSC)  reactions (31) were performed by standard techniques. The sheep cells were 
sensitized with rabbit amboceptor in one-fifth the minimum agglutinating dose. Sensitized hu- 
man red cell reactions (RA Rho test) were performed by a modification of the procedures of 
Gmbb (32) and of Waller and Vaughan (27) described elsewhere  (26). For such reactions, 2 per 
cent suspensions  of washed red cells were sensitized with coating reagents diluted to contain 
128 units of blocking antibody as measured by the indirect Coombs' test. Rheumatoid sera, 
diluted  1:10 and  1:100,  were added  to  1.5 per cent suspensions of coated and control non- 
coated red cells. 
Gm Typing.--Typing  of normal human sera for the hereditary ~'-globulin groups  (Gin(a) 
(9),  Gin(b)  (10),  and  Gin(x)  (11),  was performed according to the procedure of Gmbb and 
Laurell (9), except that 1.5 per cent suspensions  of red cells were employed and the tubes read 
x One hundred sera kindly furnished by Dr. Howard Ticktin, Liver Clinic, District of Co- 
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with the aid of a hand lens after 30 seconds centrifugation in a serological centrifuge  (serofuge, 
Clay-Adams, Inc.). Sera containing anti-Rh antibodies were typed after absorption of most of 
the anti-Rh activity by human red ceils of appropriate antigenic composition. Gamma globu- 
lins isolated from normal human sera were typed in an identical fashion after the protein solu- 
tions had been concentrated to 10 mg per ml. Typing of the 7S h,-globulin from sera containing 
rheumatoid factor activity  was performed after removing all rheumatoid agglutinating  activity 
by density gradient ultracentrifugation; "y-globulin from normal sera, treated in an identical 
fashion, was included as a control in such experiments. 
Block Titration.--These were performed with serial dilutions of rheumatoid sera and with 
red cells sensitized with serial dilutions of coating reagent. Separate pipettes were used for each 
dilution to prevent carry-over. 
Absorptiott Experiments.--Red cell stromata were prepared from human Ro cells by the 
method described elsewhere (33). Threefold volumes of undiluted anti-Rh reagent were added 
to the washed  stromata. After sensitization for 2 hours at 27°C the stromata were washed 
thrice with 50- to 100-fold volumes of saline. Rheumatoid sera were absorbed with the sensi- 
tized stromata (4 hours at room temperature) until serologic reactions with coated human red 
cells were no longer positive. Other aliquots of rheumatoid sera were repeatedly absorbed with 
half-fold volume of peaked sensitized sheep cells until serologic reactions in SSC test were neg- 
ative. 
Fractionation Procedures.--Starch block electrophoresis (34) and density gradient ultracen- 
trifugation.  (8) were performed  as described previously. Fractions thus obtained were titered 
for agglutinating or inhibitory activity; protein content of the fractions was measured  by a 
modified Folin-Ciocalteu reaction. When necessary, fractions were concentrated by evapora- 
tion under negative pressure. 
Analytical  ultracentrifugation was performed in a Spinco model E ultracentrifuge. 
RESULTS 
Relation  to  Specificity  to  Human  Hereditary  "g-Globulin  Groups.--With  the 
sensitized human red cell test system it was possible to readily study the efficacy 
of "y-globulin  from a single individual as a "coating reagent" in tests with various 
rheumatoid sera. The basis for the reaction is shown in Fig. 1.0 Rho (D)-positive 
erythrocytes are sensitized by an "incomplete" anti-Rho (anti-D) serum. With 
a  given anti-Rh coat, for example anti-D  (a), addition of certain rheumatoid 
sera such as rheumatoid serum (a) produces agglutination. The use of 24 indi- 
vidual anfi-Rho sera with a  panel of 36 rheumatoid sera produced many differ- 
ent patterns of reactivity. A  summary of some of these differences is presented 
in Table I, which shows selected examples from the broader study. It is evident 
that rheumatoid serum III reacted with cells sensitized by all four of the anti-Rh 
coats, whereas rheumatoid serum IV reacted only with coat 4. Other rheumatoid 
sera such as I  and II reacted with some coats but not with others. Such differ- 
ences in reactivity were not due to differences in titer of either the rheumatoid 
serum or of the anti-R_h coat, for rheumatoid sera I  and II gave diametrically 
opposed reactions with coats 1 and 2.  Table II depicts the results of checker- 
board titrations of rheumatoid serum I  (Co)  and II (Pe) with anti-Rh coats 1 
(K 2722)  and 2  (Sw).  It is evident that differences in titer cannot explain the 
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Table III fists the agglutination patterns of 13  selected rheumatoid sera in 
reactions with red cells sensitized by 9  selected anti-Rh sera. Cells coated with 
Mu  were agglutinated by all of the  36  rheumatoid sera in  the test panel.  ~ A 
second coat, Ri, kindly furnished by Dr. Marion Waller, also reacted with all 
of the rheumatoid sera. Several other coats, such as Ki, CD, and Ga, were ag- 
Blocking  Coated  cell 
anti  D 
Coated  cell 
Agglutination 
FIG. 1. Schematic drawing of the interaction of incomplete P.h antibodies with red blood 
cells and their agglutination by rheumatoid factors of complementary specificity. The Da re- 
fers to an anti-Rho antibody of a given genetic globulin group, e.g. Gin(a) which reacts with 
RSa (a rheumatoid serum containing the complementary rheumatoid factor), e.g., anti-Gin  =. 
TABLE I 
Sdected Agglu2ination Patterns of 4 Rheumatoid Artkritgs Sera with 4 Anti-Rko  Coats. 
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mediate reactions, i.e.  agglutination by  15  to  50  per cent of the  rheumatoid 
2 Anti-D serum  Mu is supplied by Knickerbocker Blood  Bank, N. Y. Some problems  of 
exact reproducibility of results with different  specimens obtained over a 5 year period have 
been encountered. This appears to be partially due to variation in the titer of saline anti-Rh 
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sera, are not shown in this table but comprised the vast majority of the anti-R_h 
sera. None of the rheumatoid sera reacted with all 24 of the anti-Rh coats. How- 
ever, one serum, from a  normal blood donor, kindly furnished  by Dr.  F.  Mil- 
grom, did react with cells sensitized by all 24 coats. 
In general, all sera active with a given coat at 1 : 10 dilution were also reactive at a 
1 : 100 dilution; hence reactions negative at 1 : 10 dilution are listed as 0 in the table and 
those positive at 1 : 100 as +  +  to +  +  +  +, depending upon the degree of agglutina- 
tion. Only a very few sera, e.g.  Ga with coat Sw, were positive with a given coat at 1 : 10 
TABLE III 
Agglutination Patterns of 13 R.A.  Sera with  Various Sdected Anti-D Coats 
R. A. serum 
l.  Du 
2.  Ch 
3.  Co 
4.  Ga. 
5.  Do 
6.  So 
7.  Gr 
8.  He 
9.  Kv 
10.  Pa 
11.  To 
12.  Si 
13.  Ha 
Mu 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Anti-Dsource 
Ri 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Ki 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
++ 
+++ 
++ 
+++ 
+++ 
+++ 
0 
CD  Ro 
++ 
0 
++ 
++ 
++ 
++ 
~-+ 
++ 
~-+ 
++ 
++ 
0  0 
0  0 
~x 
Ga  Ask 
++  ++[+++ 
++r+++ 
++  ++1+++ 
+0  +-  0  ~+++  ++  ++ 
+-~  ++  +++ 
~-+  0 
0  ++  0 
++-  0  0 
0  0 
0  +++ 
a 
Sw 
+++ 
+++ 
0 
+ 
++ 
0 
++ 
+++ 
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0 
0 
+++ 
0 
b 
Vik 
+++ 
+++ 
+++ 
o 
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0 
++ 
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and negative at 1 : 100; these are listed as +. These results are in keeping with those of 
Grubb (9), who found that the inhibitory capacities of Gm(a  +) compared to Gin(a--) 
sera were not all or none, but rather about tenfold. 
Many  different  agglutination  patterns  were  demonstrable  and  some  were 
shown to be correlated with the presence or absence of the known,  genetically 
determined 5,-globulin groups  (Gin groups) in the anti-Rh sera. The sera con- 
taining  the  anti-Rh  antibodies were  themselves  typed for  their  own  genetic 
"y-globulin groups in the standard inhibition test systems (9-11)  after absorp- 
tion of anti-Rh activity. In Table III the six coats on the left are all heterozy- 
gous for the genetic alleles Gm(a)  and Gm(b). The three anti-Rh coats at the 
right  serve  as  reagents  in  the  inhibition test  for  typing normal  sera  for  the 
genetic ~/-globulin groups Gin(a) and Gm(x). Because our clinic population in- 
cluded no Negro patients with rheumatoid arthritis, Gm-like, which is present 
only  in  Negroes  (12,  19),  was  not  studied.  Further,  genetically determined H.  H.  ~'UDENBERG  AND  H.  G.  KUNKEL  263 
erythrocyte antigens previously assumed to be identical in Negroes and whites 
have recently been demonstrated to be qualitatively different in Negroes and 
whites (35).  Since similar factors may complicate the genetically determined 
~/-globulin groups, the present studies avoided use of serologic reagents obtained 
from Negroes. 
Note that rheumatoid sera 7  (Gr)  and 8  (He)  gave identical agglutination 
patterns; they reacted only with the coats containing the hereditary "y-globulin 
group Gin(a) and failed to react with the only coats lacking the Gm(a) prop- 
erty; namely, Vik) These two rheumatoid sera, He and Gr, are useful for typing 
normal human sera as Gm(a+)  or Gin(a--)  in the standard typing system. 
Three  additional rheumatoid  sera  obtained  from Dr.  Grnbb,  also  useful as 
Gm(a) typing reagents, gave agglutination patterns identical with those of He 
and Gr with the panel of anti-Rh coats. Similarly, rheumatoid serum  9  (Kv), 
useful as a  typing reagent for the Gin(b) factor, failed to agglutinate the two 
coats lacking this factor, namely Sw and Ask, but agglutinated all the other 
coats, all Gm(b) positive. Rheumatoid serum 6 (So),  useful for Gm(x) typing, 
failed to react with standard reagents Sw  and Vik, both lacking the  Gm(x) 
property,  but  reacted with  standard  reagent  Ask  which  possess  the  Gm(x) 
factor. 
Table  IiI  also  illustrates  eleven  different  agglutination patterns  demon- 
strable  with  the  panel  of rheumatoid sera.  Rheumatoid serum  13  only ag- 
glutinated cells coated with one anti-Rh reagent (Ask)  other than the univer- 
sally reactive Mu and Ri coats; these were the only coats in the 24 tested with 
which serum 13 reacted. Serum 12 showed a different pattern of reactivity, indi- 
cating the presence of at least a second agglutinating factor of different specific- 
ity. Serum 11 reacted with two additional coats, CD and Ro, not agglutinated 
by either serum 13 or 12, indicating an additional agglutinating factor, either a 
separate factor or one present in the same serum in addition to the others. 
Serum 10 reacted with still another coat, Ga, adding a fourth factor. Proceeding 
in this fashion with further sera, a total of eight factors of differing specificity 
are demonstrable and, undoubtedly, several  more exist. Similar agglutination 
patterns revealing at least eight specificities  were duplicated with various of 
the other 36 rheumatoid sere in the test panel. 
With rare exceptions, several specific factors were present in combination in 
each rheumatoid serum. This could be demonstrated directly by differential 
absorption of the rheumatoid sera with selected coats. With such absorption, 
reactivity with some coats vanished, leaving reactivity for other coats behind, 
as is illustrated in Table IV. Similar multiple specificities of rheumatoid factor 
in the same serum have previously been demonstrated in a few sera thoroughly 
studied by other methods (36, 37). 
a  Agglutination  patterns identical to Vik were obtained with D25, another anti-Rh serum 
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TABLE  IV 
Effect of Absorption of Rheumatoid Sera by Individual Human "Coats" 
R. A. serum 
GR (anti-Gm(a)) 
Absorbed with Mu 
Absorbed with Sw 
Control non-absorbed 
Cd. 
Absorbed with Mu 
Absorbed with CD 
Absorbed with Sw 
Control non-absorbed 
Test coat 
Titers 
Mu  Sw 
0  0 
160  0 
160  80 
0  0 
8O  0 
8O  0 
CD  Latex fixation 
0  2O 
0  200 
10  4OO 
80  12,800  160  40 
TABLE  V 
Comparison of the Agglutination Patterns of Various R.A. Sera with Cells Coated with Anti-C 
and  Anti-D  Antibodies from  the  Same Serum 
R. A. serum  rh'(Cde) eeUs  Ro(cDe)cells 
Du 
Ga 
Co 
Ha 
Mc 
Do 
Si 
Pe 
T.Ca 
To 
R.Ca. 
He 
Bo 
Gr 
So 
Kv 
Pa 
St. 
Fa 
We 
So 
Wa 
Fo 
Hu 
Be 
++ 
++ 
++ 
0 
+++ 
++ 
++++ 
++ 
+++ 
+++ 
+++ 
0 
0 
++++ 
++++ 
+++ 
++++ 
+++ 
+++ 
0 
0 
0 
0 
+++ 
++ 
++ 
+++ 
0 
+++ 
+ 
+ 
++++ 
++ 
+++ 
+++ 
+++ 
0 
0 
++++ 
++++ 
++ 
++++ 
+++ 
++++ 
0 
0 
0 
0 
+++ H. H. ~'UDENBERG AND  H. G. KUNKEL  265 
When coating reagents containing antibodies of different specificities against 
red cells were used to coat the corresponding red cells, identical results were ob- 
tained in agglutination reactions with the panel of rheumatoid sera. Table V 
demonstrates the results of such agglutination tests with anti-rh'  (anti-C)  and 
anti-Rho (anti-D) blocking antibodies present in the same serum, but separable 
by differential absorption. When this serum was used to coat C+D-- (rh') and 
C--D+(Ro)  cells,  respectively, with  equivalent  doses  of blocking antibody, 
the two sets of coated ceils gave identical reactions with the rheumatoid panel, 
as is evident from Table V. Similar results were obtained with another antisera 
containing two  separable  incomplete antibodies.  Identical agglutination pat- 
terns with the panel of rheumatoid sera were also obtained when  serial  speci- 
mens of anti-Rh antibodies from the same individual were used as coats. In two 
donors, three specimens were obtained during a  2 year period during which 
immunization continued; coded specimens from a given donor produced identi- 
cal results in double-blind tests. 
Relation of the "Human 33-Globulin Factor" to the "Rabbit 33-Globulin Factor." 
The sera of eight normal rabbits of different rabbit 5'-globulin groups  4 were 
tested in standard Gm test systems for the Gin(a), Gin(b), Gin(x), and Gin-like 
inhibitory properties after prior absorption of the rabbit sera with uncoated 
human red cells. All of the rabbit sera were found to lack the inhibitory proper- 
ties corresponding to the human genetic 33-globulin groups. 
Attempts to inhibit the sensitized  sheep cell reactions of two rheumatoid sera of 
anti-Gm(a) specificity with Gm(a  +) and Gm(a--) human "/-globulin were uniformly un- 
successful under conditions where dear inhibition would be obtained in the Rh system. 
Further,  use  of  individual  rabbit  amboceptors,  rather  than  the pool  commonly 
employed, failed to distinguish differences in specificities of rheumatoid factors to indi- 
vidual rabbit "/-globulins (Table VI). A given rheumatoid serum invariably gave equiv- 
alent titers (differences within two tubes) with the various individual rabbit ambocep- 
tots employed. In these experiments,  rheumatoid sera which reacted with a relatively 
small number of human Rh coats were purposely utilized. However, these too reacted 
with all the rabbit antibody coats. Previous experiments by Vaughan  (38-40) demon- 
strated that absorption of rheumatoid sera with sensitized sheep cells failed to remove 
all the activity for cells coated with human incomplete Rh antibodies. A similar experi- 
ment is illustrated in Table VII. All serologic activity directed against rabbit'/-globu- 
lin was removed, while only moderate reduction of serologic activity against human 
"/-globulin, as measured by the sensitized  human cell, F-II latex fixation,  and F-II 
tanned cell methods, was obtained. 
Specificity of "Rheumatoid Factors" in Non-Rheumatoid Serum.--Sera from pa- 
tients with various forms of chronic hepatic disease, sarcoidosis, Waldenstr6m's 
macroglobulinemia, idiopathic pulmonary fibrosis, and other conditions char- 
acterized by the  frequent occurrence of positive  tests for rheumatoid factor 
4 These typed sera were furnished by Dr. Sheldon Dray. 266  RHEUMATOID  FACTORS  AND  GAM'~A  GLOBULIN 
with human 3'-globulin as the reactant, were tested by F-II latex fixation, F-II 
tanned cell, sensitized sheep cell, and Mu-coated human cell reactions. Selected 
positive  sera were also  tested  against  the panel  of individual  Rh coats.  As is 
illustrated by the examples in Table VIII, such non-rheumatoid sera showed a 
TABLE VI 
Endpoints of Sensitized Sheep Cell Reactions of  Various Sera with Individual  A mboveptors 
Numbers represent  twofold serial dilutions of rheumatoid serum beginning at 1:9 dilution. 
Amboceptor. 
Serum 
Co 
Ga 
Pe 
Ha 
Do 
To 
Normal 
1( 
)  g 
L  II 
) 
L  11 
)  1( 
L  1 
) 
) 
) 
) 
) 
) 
Saline 
TABLE VII 
Effect of Absorption of Rabbit Antibody Factor  from Rheumatoid Arthritis  Sera 
R. A. Serum 
Ga 
Absorbed with sensitized sheep 
cell 
Non-absorbed control 
Du 
Absorbed with sensitized sheep 
cell 
Non-absorbed control 
Sensitized 
sheep cell 
0 
10,240 
0 
128,000 
Titers 
Human cells sensitized with 
+Mu  Ri  Sw 
200  400  100 
800  800  200 
400  400  I00 
1,600  1,600  200 
Late~ fixation 
4,000 
16,000 
8,000 
256,000 
limited range of specificity with the anti-Rh coats. The majority of these sera 
were negative in the sensitized sheep cell reaction despite high titers in the tests 
using human "r-globulin on particulate  materials.  Case Fe  (Table VIII) where 
the sensitized sheep cell test was positive showed a broader reactivity with the 
various Rh coats resembling that seen in the rheumatoid arthritis  sera. 
One serum from a  normal blood donor (kindly furnished by Dr.  Felix  Mil- 
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serum showed an even broader reactivity than  the rheumatoid  arthritis  sera. 
These observations confirm those of Milgrom (41)  and indicate  that the Mil- 
grom factor differs from ordinary rheumatoid factors as  well  as  those  usually 
observed in other disorders. 
A utospecificity  versus IsoSpecificity.--The  possibility of preferential  specific- 
ity of the patient's own rheumatoid factor for his own genetic type of T-globulin 
was investigated by two methods.  The first,  illustrated  in Table III, involves 
reaction of the patient's serum with his own Rh antibody. Rheumatoid serum 4 
TABLE VIII 
Agglutination  Patterns  of Various Non-Rheumatoid  Sera  Strongly  Positive by Latex Fixation, 
with Variou3 Angi-D  ,,oats 
aeruln 
3arcoid 
Wa 
Fo 
Re 
Liver Disease 
Blu 
War 
DC 4 
Macroglobulinemia 
Hu 
Be 
Miscellaneous 
So 
Ca 
Fe 
Mu  Ri 
++  +++ 
++  ++ 
++  0 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
0 
+++ 
0 
0 
4- 
7397  Bre 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
+  + 
Ax  bc 
Ask  Saw  Wa 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
O  0  0 
0  0  0 
O  0  0 
0  0  0 
0  ++  0 
b  Sensitized 
Vik  sheep eel]. 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  +++ 
(Ga)  was obtained from an elderly patient with rheumatoid arthritis  who was 
Rh-negative. Following immunization with Rho-positive erythrocytes, a potent 
anti-Rho antiserum  was produced.  The pre-immunization  rheumatoid  serum, 
while  reactive with red cells sensitized  by most other anti-Rh  coats, failed to 
react with red cells coated with the patient's own anti-Rh antibody, although 
as is evident from Table III, most other, rheumatoid sera reacted well with this 
anti-Rh  coat.  Similar  results  have  been  obtained  in  one  other  patient  so 
immunized. 
The anti-Rh antibody portion of the "r-globulin cannot be distinguished from 
the remainder of the 7S ~,-globulin carrying the genetic (Gm) groups by current 
physical and chemical methods  (42).  However, the possibility exists that this 
antibody does not carry all  the  antigenic  determinants  found in the  total  7S 268  RHEUMATOID  ]~ACTORS  AND  GAMM~  GLOBULIN 
3"-globulin,  although the finding of the same antigenic  (Gin) specifidty in two 
different antibodies  (as described above) is somewhat against this hypothesis. 
In order to test whether the non-reactivity of the patient's own rheumatoid factor 
involves not only his own anti-Rh antibody but all of his 7S "g-globulin, the following 
experiments were carried out. The 7S "g-globulin, in which the Gm group specificities 
wholly reside  (42), was separated from the 19S "g-globulin of various rheumatoid sera 
by density gradient ultracentrffugation in order to free it from rheumatoid factor ag- 
glutinating activity. When a rheumatoid serum containing only one specificity of rheu- 
matoid factor, namely anti-Gm(a), was thus separated and the 7  S -g-globulin typed for 
its genetic groups in standard Gm-typing systems, it was found that the 7S "),-globulin 
lacked the  Gmfa) antigen, but instead contained the genetic allele,  Gin(b).  This is 
shown in Table IX. Similarly,  the 7S "g-globulin of a rheumatoid serum of anti-Gm(b) 
specificity  was itself  Gin(b-) but possessed the genetic allele  Gm(a) and the 7S 3"- 
globulin of a rheumatoid serum of anti-Gin(x) specificity and was itself Gin(x-). Re- 
sults obtained with 7S 3'-globnlins of such specific sera isolated by density gradient 
ultracentrifugation are depicted in Table X. 
Similar results were also obtained in one experiment in which the 7S and 19S 
3"-globulins  were separated by DEAE column chromatography rather than by 
density gradient  ultracentrifugation.  Hence  the  rheumatoid  factors obtained 
from  certain  rheumatoid  sera  appeared  to  be  specifically  directed  toward 
genetic groups not present in the ")'-globulin of the given serum. Although only 
relatively few rheumatoid factors were studied,  these findings were invariably 
true for those rheumatoid factors useful as typing reagents for one or another 
of the Gm groups. However, among other sera, not useful as typing sera, evi- 
dence of inhibition by the patient's own 7S 3"-globulins  was obtained. This was 
most evident from strong prozone reactions which disappeared when the rheu- 
matoid factors were isolated by ultracentrifugation  and  thus  separated  from 
the patient's own 3"-globulin.  In addition,  observations with isolated rheuma- 
toid factors indicated occasional instances in which these were clearly positive 
with a given Rh coat while the whole serum was negative. Here the 3"-globulin 
in the serum was of the same type as the rheumatoid factor specificity and auto- 
inhibition occurred. These results will be published in detail separately (43). 
Reactivity of Different 3"-Globulins with Rheumatoid Factors to Give "22S Corn- 
plexes."--Previous studies have indicated that the rheumatoid factors combine 
with ")'-globulin to give what has been termed the 22S  complex (2,  3).  This is 
observed in whole sera of patients with large amounts of rheumatoid factors. 
Recently, it has been demonstrated  that  isolated preparations of rheumatoid 
factors with an s rate of approximately 19S acquire an s rate close to 22S  and 
an increase in  area on  the  addition  of ordinary 3"-globulin  (4).  This complex 
formation also is readily seen on the addition of isolated rheumatoid factor to 
normal serum; a  22S  component similar to  those observed in  arthritis  sera is 
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In view  of  the  differences in  reactivity of various  rheumatoid  factors  with 
different genetic types of 3,-globulin noted above, it seemed of interest to deter- 
mine whether  these differences would  also be apparent  in  respect to  complex 
formation.  Initial  experiments  demonstrated  that  the  addition  of  isolated 
rheumatoid factor to a  Gin(a+) serum and to a  Gm(a-)  serum resulted in each 
instance in formation of a  22S component.  However, in view of the findings of 
many more types of 3'-globulin through  the reactivity of different rheumatoid 
factors  with  various  Rh  coats,  this  experiment  did  not  furnish  a  conclusive 
answer. Therefore, rheumatoid factor was isolated from serum Ga by methods 
described previously. One of these preparations is illustrated in the upper por- 
TABLE  IX 
Inhibitory  Aclivily  of Isolated  7S  y-globulin  ]?om Anti-Gin(a)  Rhezonatoid  Arthritis  Serum 
Mg/rnl 7S ~/-glohulin  of serum 19N added. 
System 
Anti-Gm(a) 
.\nti-Gm(b) 
2.0  I  0.5  0.125  0.03  Saline 
TABLE  X 
Genetic  -/-Globulin  Groups  of Individuals with Rheumatoid Factor of a  Single Specificity 
Rheumatoid  factor specificity 
Anli-Gm  (a) 
.\nti-Gm  (b) 
Anti-Gm(.x:) 
No. tested  Genetic  type of isolated  7S  3  globulin 
Gin(a-b+) 
G-m  (a-t-b-  ) 
Gm(a+b+.~:-  ) 
tion  of  Fig.  2.  This  preparation  was  added  to  four  different  sera  which  con- 
tained anti-Rh  antibodies utilized in  the  above agglutination studies.  Two  of 
these sera contained Rh antibodies that reacted strongly with this rheumatoid 
factor; the other two contained non-reactive Rh antibodies. On the addition of 
rheumatoid factor Ga, all the added material complexed with the 3"-globulin in 
the  serum  to  give equal amounts of 22S  complex in  all four sera.  Part  of this 
experiment is illustrated in Fig. 2. The lower portion of this figure shows a  pat- 
tern of one of the nonreactive sera before (a) and after (b) the addition of rheu- 
matoid factor Ga. The new peak is the 22S complex sedimenting slightly faster 
than  the normal  19S;  the pattern  (c)  shows  the  effect of addition of an  equal 
concentration of this rheumatoid factor on a reactive serum. The amount of 22S 
complex is very similar in the two types of sera. As controls for this experiment 
it was determined that  isolated rheumatoid factor  Ga sedimented exactly the 
same  as  a  standard  Waldenstr6m  macroglobulin  (equal  mixtures  of  the  two 270  RHEUMATOID  FACTORS  AND  GAMMA  GLOBULIN 
gave one peak with an s rate of 18.7S). Addition of the standard macroglobulin 
to  these  two  sera  caused  accentuation  of  the  normal  19S  peak only, without 
producing a  22S complex as always occurred with rheumatoid factor. 
FIG. 2. Ultracentrifuge patterns of isolated rheumatoid factor (upper) and a human serum 
containing a  "non-reactive" anti-Rh antibody before  (a)  and after  (b)  addition of isolated 
rheumatoid factor.  The effect of an equal concentration  of this rheumatoid factor on serum 
containing a  reactive anti-Rh antibody is illustrated in  (c). 22S complexes (arrows)  formed 
equally well with both types of sera. 
Similar results were obtained with rheumatoid factor isolated from a different 
serum.  Serum  Bomb.  (kindly furnished by Dr.  Arthur Steinberg) is known  to 
be a powerful anti-Gm (b) serum. A highly purified preparation of  19S  rheuma- 
toid factor was  isolated by precipitation and  ultracentrifuge  techniques.  The 
addition of Gm(b) negative 3,-globulin to this isolated material caused complete 
conversion to 22S complex to the same degree as the addition of Gin(b) positive 
3,-globulin. The  reactivity of 3,-globulin with  rheumatoid factor to give a  22S 
complex appeared to be a  universal property of different 3,-globulins unrelated 
to the specificity in the Rh system. 
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It also seemed of interest to determine whether the specificity of the sensitized 
Rh cell system was reflected in the precipitating action of rheumatoid factors 
with soluble "y-globulin aggregates. Pooled F-II'r-globulin has usually been em- 
ployed in this reaction following aggregation by heating (2-4).  Five prepara- 
tions of ,/-globulin separated from normal serum by zone electrophoresis were 
concentrated to I0 mg per ml and aggregated by heating at 63°C for 10 minutes. 
All preparations failed to react with rheumatoid factor prior to heating. Table 
XI shows the results of precipitin tests for these five preparations with four 
different rheumatoid sera. Each preparation was active with all of the different 
sera. Of particular interest is serum Hu which reacted strongly only with Rh 
coat Mu out of approximately 35 different anti-Rh sera tested, but still gave a 
strong precipitin reaction with all five of the ~,-globulin  preparations. Gamma 
TABLE  XI 
Reactivity of Different Aggregated y-globulin Preparations from 
l~fferent Individuals  vAth Various RheumatMd Sera 
~-Globulin 
preparation 
I 
II 
iU 
IV 
V 
Ga 
Rheumatoid serum 
Ga 
++++ 
++ 
+++ 
+++ 
+ 
+++ 
Ha 
++++ 
++ 
+++ 
+++ 
++ 
+++ 
Hu 
++++ 
+++ 
++++ 
+++ 
++ 
+++ 
Fa 
++++ 
++ 
+++ 
+++ 
+ 
+++ 
Normal 
serum 
globulin was  also prepared  from rheumatoid serum  Ga and the  rheumatoid 
factor removed by ultracentrifugation. This 3'-globulin, when heated, reacted 
with all the rheumatoid sera. It also reacted well with rheumatoid factor in the 
serum from which it was obtained. The anti-Rh coat from this same serum failed 
to react with the homologous rheumatoid factor. In these systems no selec- 
tivity comparable to that in the anti-Rh system could be demonstrated for the 
precipitin reaction. 
The above observations were carried out primarily with systems where the 
Gm specificity of the rheumatoid factors and Rh coats were not clearly identi- 
fied. In view of the recent observations of Steinberg and Stauffer (44),  that 
heating of sera alters their specificity in the Gm inhibition system in some in- 
stances and not in others, this problem was investigated with isolated "r-globulin 
aggregates from "r-globulin of known genetic type. Gm(a--) "r-globulin became 
strongly inhibitory in the Gin(a) system when aggregates were formed and the 
isolated aggregates tested. This is in line with the above observations. However, 
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a striking difference between these two systems. These results are continuing and 
will be published in detail elsewhere (45). 
DISCUSSION 
It seems highly likely that the eight different specificities of rheumatoid factor 
demonstrated by the sensitized human cell technique in the present studies will 
define at least eight genetically determined ~,-globulin groups in man. Four such 
hereditary groups have already been delineated by employing the inhibition 
system of Grubb and Laurell in family studies (9, 10). Such genetic differences 
in human "/-globulin, analogous to  the genetic differences in the  antigens in 
human red cells, and the differing specificities  of their complementary rheuma- 
toid factors suggest that the latter are antibodies directed against the genetically 
determined "antigens" in human 3'-globulin.  Physical, chemical, and immuno- 
chemical evidence to support the antibody concept of "rheumatoid factor" has 
been accumulated during the past few years (2-5), but evidence of such marked 
specificity has not hitherto been brought forward. 
The specificity has thus far been demonstrated only through the use of incom- 
plete  antibodies.  However,  the  same  specificity was  obtained  with  anti-rh' 
(anti-C) and anti-Rho (anti-D) antibodies when these were present in the same 
serum. The results of inhibition studies with the "/-globulin of normal serum in- 
dicate that similar specifieities  are present in the "/-globulin even when such 
antibodies are not detectable. Absorption experiments with Rh antisera have 
demonstrated that the 'r-globulin lacking the anti-Rh antibody corresponds in 
genetic type to the incomplete antibodies of each individual serum. This was 
demonstrated by removing all anti-Rh activity of selected sera by absorption 
with Rh-positive erythrocyte stromata. The sera were then typed for the vari- 
ous  Gm  groups  in  standard  inhibition  systems.  However,  the  question  of 
whether all "r-globulin  molecules possess  this  specificity, still  remains unan- 
swered.  It  seems possible  that certain other  molecules in  the  population  of 
")'-globulins are responsible for precipitin reactions with aggregates and for com- 
plex formation. These reactions fail in most instances to show specificity, but 
other explanations appear more reasonable. 
Attempts to reproduce agglutination and agglutination-inhibition reactivity 
for latex particles and tanned red cells  coated with 3'-globulin from selected 
individuals failed to demonstrate specificity and all Gm types were agglutinated 
by different rheumatoid factors,  and no  differential inhibitory capacity was 
demonstrable in sera of differing Gm types.  These  results might be  in part 
explainable on the basis of aggregates of "/-globulin coating the particles. How- 
ever, special efforts were made to utilize 7S "/-globulin freed from aggregates by 
centrifugation as coating for the latex particles. It was evident that 7S "/-globu- 
lin functioned well as coating material but no specificity could be demonstrated. 
Seven different individual "/-globulins were utilized and they reacted with all of 
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cause of strong specificity in the anti-Rh system. Efforts were also directed 
toward showing specificity in a  streptococcal antibody system similar to that 
described by Ling and Gibson (46) in which streptococcal antigens are applied 
to red blood cells, followed by subagglutinating concentrations of antibody from 
certain normal sera. Again, no specificity for agglutination by certain rheuma- 
toid sera could be demonstrated, although a  completely satisfactory system 
was not obtained because of technical difficulties. 
Special mention should be made of the uniformly positive reactions of rheu- 
matoid sera,  irrespective  of specificity, with coats Mu and Ri.  None of the 
other 22 coats in the test panel, and none of the additional 27 anti-Rh sera used 
in screening tests for this purpose showed similar universal reactivity. Presum- 
ably sera  Mu and Ri are  heterozygotic for every pair of genetic "r-globulin 
groups, and thus are analogous to the rare human erythrocytes heterozygous 
for and thus possessing  all the various erythrocyte antigens. Such red cells  6 pro- 
vide extremely useful tools for screening human sera for the presence of any 
antibody directed against a genetically determined antigen in human erythro- 
cytes. 
The failure of Gm(a+) human'y-globulin to inhibit the agglutination of sensi- 
tized sheep cells by rheumatoid sera of anti-Gm(a) specificity strongly implies 
that the specificity of the rheumatoid factors directed against human "r-globu- 
lin is completely divorced from the specificity of the factors directed  against 
rabbit "r-globulin.  In  addition,  inhibitory properties  corresponding  to  those 
delineated for the known human "r-globulin groups were not found in the "r-glob- 
ulin of rabbits when tested in the human Rh systems. The panel of rheumatoid 
factors also displayed no differences in agglutination patterns when individual 
rabbit amboceptors were employed in the sensitized sheep cell test instead of 
the pooled commercial amboceptor commonly utilized. 
Previous observations (2, 4), as well as those presented in this study, demon- 
strated that the rheumatoid factors were capable of reacting with the patient's 
own "r-globulin to form the 22S complex. In addition, soluble aggregates of the 
patient's own "r-globulin gave precipitates with his rheumatoid factors. Thus 
there  appears  little doubt that some affinity exists between  the rheumatoid 
factors and the patient's own "r-globulin.  This is compatible with the concept 
that  these  factors represent  autoantibodies to  the  patient's own "r-globulin. 
However, the striking finding that certain rheumatoid factors failed to react 
with the patient's "r-globulin in the highly specific incomplete Rh system, while 
reacting well with that of other persons of different  genetic types raises the 
possibility that these proteins actually are isoantibodies analogous to the iso- 
hemagglutinins. In the latter case, persons of blood group A, for example, whose 
red cells contain the A but lack the B  antigen produce anti-B isoagglutinins. 
Current evidence on the mechanism of production of these isoagglutinins sug- 
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gests that they are produced from bacterial antigens which cross-react with A 
and B substances on the red cell (47). In the situation mentioned, anti-B hemag- 
glutinins are produced but anti-A isoagglutinins are not detectable in the pres- 
ence of A substance on the individual's cells, either because of tolerance or be- 
cause of self-absorption mechanisms. It is possible that a  similar  mechanism 
applies to the production of rheumatoid factors. A foreign antigen which cross- 
reacts  with  "y-globulin  may produce  rheumatoid  factor  "antibodies"  which 
likewise fail to react with the patient's own 3'-globulin because of tolerance or 
self-absorption mechanisms, but  react with the  3'-globulin  antigens of other 
persons. The universal autospecifcity demonstrated in the 22S complex forma- 
tion is not so readily explained by this concept. 
Another explanation for the apparent isoantibody nature of certain of the 
rheumatoid factors, which is still compatible with the autoantibody hypothesis, 
is a  concept envisaging the rheumatoid factors as antibodies to minor deter- 
minants on the patient's q,-globulin,  which nonetheless represent major deter- 
minants in'r-globulin of a different genetic type. Antibodies against the patient's 
major determinants would either fail to form or would be rapidly absorbed. 
Some precedence for such a concept is seen in the case of the autoantibodies to 
red cells  in acquired hemolytic anemia of the warm variety. Here,  the anti- 
bodies are rarely to the dominant Rho antigens but are usually directed against 
relative weak (rh") antigen (48). Also, in the work of Mackay and associates, 
in  certain  instances  complement-fixing  antibodies,  measured  with  whole 
tissue extracts reacted poorly with the extracts from the patient's own tissues 
(49)  compared  to  their  reactions  with  extracts  from  tissues  of  other  indi- 
viduals. The difficulty with such a  concept for the "g-globulins is that it pre- 
supposes the presence of small amounts of the foreign genetic determinants in 
the  patient's ~,-globulin,  either  in  the  buried  state  on  the  dominant  mole- 
cules or on minor constituents of the "r-globulin. This has not as yet been demon- 
strated.  Current  evidence  does  not  permit  complete  evaluation  of  these 
hypotheses. In any event, it would appear that the patient's own genetically de- 
termined "r-globulin  type frequently restricts the specificity of his circulating 
rheumatoid factor, so that "iso-specificity" exists. 
One explanation for the failure of certain rheumatoid arthritis sera to react 
with their own anti-Rh coats is that the anti-Rh antibodies obtained, despite 
their high titer, represented only a limited number of specificities  arising early 
in immunization. More prolonged immunization might lead to broader antigenic 
specifcities for the Rh antibodies, including some which would react with the 
patient's own rheumatoid factors. This hypothesis requires further investiga- 
tion, especially since  "broadening of specificity" with eventual autoreactivity 
following prolonged  isoimmunization,  has  been  observed  before  with other 
antigen-antibody systems  (50,  51).  However,  anti-Rh  coat  Ga,  which  was 
studied in greatest detail, reacted well with the majority of rheumatoid arthritis 
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in striking contrast to the broad reactivity of this Rh antibody coat. In addi- 
tion, the results of the inhibition studies with the 7S "},-globulin of rheumatoid 
arthritis sera containing rheumatoid factors of defined specificities clearly indi- 
cated a general absence of the 7-globulin specificity toward which the rheuma- 
toid  factors  were  directed.  This  apparent  isospecificity however in  certain 
instances does broaden into autospecificity, even in the Rh system, as was demon- 
strated above with isolated rheumatoid factors. It is most clearly and constantly 
observed in the 22S complex formation. Additional evidence for the occurrence 
of both auto- and isospecificity for rheumatoid factors has been obtained  re- 
cently by Harboe  (52).  The situation may be analogous to  that recently de- 
scribed for pancreatic antibodies (53).  Although these are  frequently isoanti- 
bodies, autoantibodies have been observed. 
Well  delineated isoantibodies have  been  produced  by Oudin  (20-22)  and 
others  (23-25)  by deliberately immunizing individual rabbits with ~'-globulin 
obtained from rabbits of differing  "}'-globulin "allotype" (20). The serum of such 
isoimmunized rabbits bears a strong similarity to that of patients with rheuma- 
toid factor; namely, specificity for a genetically determined ~,-globulin not pres- 
ent in the immunized rabbit.  However, there are also differences. The rabbit 
antibodies are typical low molecular types (54) in contradistinction to the high 
molecular weight rheumatoid factors. In addition, the rheumatoid factors form 
a  complex with the patient's own "}'-globulin, hence demonstrating a  general 
affinity for "},-globulin that extends beyond the specificity demonstrated in the 
Rh system. This does not appear to be true of the antibodies in the rabbit. A 
situation perhaps resembling that in the human is found in the recent work of 
Milgrom, and associates (55):  Reinjection of the rabbits' own "},-globulin pro- 
duced antibodies which reacted with human ~,-globulin.  The authors postulate 
that the rabbit "},-globulin is modified in preparation and that antibodies pro- 
duced  to  such  altered  determinants  react  better  with  unmodified  human 
"y-globulin  than with unmodified rabbit "y-globulin.  These  results have been 
confirmed in this laboratory and the question of isospecificity in regard to the 
reactivity with "y-globulin  of other rabbits has been investigated. Thus far a 
reaction has only been obtained with foreign "y-globulin and no such isospecific- 
ity has been demonstrated in this rabbit system (54). 
SUMMARY 
Rheumatoid factors in the sera of patients with rheumatoid arthritis appear 
to be specifically directed against genetically determined "antigens" in human 
"},-globulin. At least eight rheumatoid factors of differing specificity exist; usually 
several are present in combination in the same serum. The  different rheuma- 
toid factors can be readily detected through their pattern of reactivity with 
anti-Rh antibodies from different individuals. Rheumatoid factors  in diseases 
other than rheumatoid arthritis were found to have a more restricted specificity, 
contrasted to the broader reactivity of the factors in most rheumatoid arthritis 276  RHEUMATOID  FACTORS  AND  GAMMA  GLOBULIN 
sera.  A  specificity similar to  that  for incomplete antibodies  was not  demon- 
strated  for the  reaction of rheumatoid  factors with  aggregated "y-globulin or 
with 7-globulin to form the "22S complex." 
In  certain  instances,  using  the  anti-Rh  system,  rheumatoid  factors  were 
found to react poorly with the patient's own v-globulin, compared to  that of 
other individuals of different genetic 3'-globulin types. These results, as well as 
additional indirect evidence, indicate that the rheumatoid factors can  possess 
isospecificity. However, a certain degree of autospecificity was also found which 
was most  clearly evident  through  complex formation  with  the  patients  own 
y-globulin and in the reaction with aggregates. The relevance of these findings 
to possible isoantibody as well as autoantibody concepts is discussed. 
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